{"transactions":[{"id":1700339,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":95849,"kind":"person","name":"Rombotis Spiro George","position":1,"cik":"0001357396","reported_name":"Rombotis Spiro George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Warrants (right to buy)","published_at":"2023-12-26T21:05:23.000Z","date":"2023-12-21","kind":"purchase","planned":false,"acquired":true,"shares":6070,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of common stock was purchased with an accompanying warrant at an aggregate purchase price of $3.315 per share and accompanying warrant."}],"balance_after":6070,"derivative":{"exercise_price":3.19,"exercise_date":"2023-12-21","expiration_date":"2030-12-21","underlying":"Common Stock","underlying_shares":6070},"source":{"system":"sec-edgar","filing":"0001104659-23-129185","document":"tm2333679-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923129185/tm2333679-2_4seq1.xml","form_type":"4"}},{"id":1700338,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":95849,"kind":"person","name":"Rombotis Spiro George","position":1,"cik":"0001357396","reported_name":"Rombotis Spiro George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-26T21:05:23.000Z","date":"2023-12-21","kind":"purchase","planned":false,"acquired":true,"shares":6070,"price":3.315,"value":20122.05,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Reporting Person purchased unregistered shares of the Issuer's common stock in a private placement, pursuant to a Securities Purchase Agreement between the Reporting Person and the Issuer."}],"balance_after":68658,"source":{"system":"sec-edgar","filing":"0001104659-23-129185","document":"tm2333679-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923129185/tm2333679-2_4seq1.xml","form_type":"4"}},{"id":1839976,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":95849,"kind":"person","name":"Rombotis Spiro George","position":1,"cik":"0001357396","reported_name":"Rombotis Spiro George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2023-07-03T20:58:13.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person received an award of 110,000 options on June 30, 2023, which shall vest in full on June 30, 2026, provided, however, that if certain clinical milestones are achieved then such options shall vest in full earlier in connection with such achievement."}],"balance_after":110000,"derivative":{"exercise_price":0.5891,"exercise_date":"2024-06-30","expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001104659-23-077661","document":"tm2320411-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923077661/tm2320411-9_4seq1.xml","form_type":"4"}},{"id":2036692,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":95849,"kind":"person","name":"Rombotis Spiro George","position":1,"cik":"0001357396","reported_name":"Rombotis Spiro George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-02T21:18:24.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":57600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 57,600 restricted stock units on January 31, 2023, which shall vest in full on January 31, 2026, provided, however, that if certain clinical milestones are achieved then such restricted stock units shall vest in full earlier in connection with such achievement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,988 shares of common stock and 57,600 restricted stock units."}],"balance_after":62588,"source":{"system":"sec-edgar","filing":"0001104659-23-009910","document":"tm235262-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923009910/tm235262-2_4seq1.xml","form_type":"4"}},{"id":2470261,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":95849,"kind":"person","name":"Rombotis Spiro George","position":1,"cik":"0001357396","reported_name":"Rombotis Spiro George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-16T21:16:22.000Z","date":"2021-12-13","kind":"grant","acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted as part of the Issuer's annual compensation review to executive officers."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"This Form 4 is being amended to correct a typographical error in the number of shares of Common Stock underlying the options granted to the reporting person on December 13, 2021. 190,000 shares of Common Stock underlie the granted options."}],"balance_after":190000,"derivative":{"exercise_price":3.45,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001104659-21-150527","document":"tm2135616d1_4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465921150527/tm2135616d1_4a.xml","form_type":"4/A","original_submission_date":"2021-12-15"}},{"id":2472021,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":95849,"kind":"person","name":"Rombotis Spiro George","position":1,"cik":"0001357396","reported_name":"Rombotis Spiro George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-15T21:20:03.000Z","date":"2021-12-13","kind":"grant","acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted as part of the Issuer's annual compensation review to executive officers."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis."}],"balance_after":190000,"derivative":{"exercise_price":3.45,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001104659-21-150003","document":"tm2135363d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465921150003/tm2135363d3_4.xml","form_type":"4"}},{"id":2501234,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":95849,"kind":"person","name":"Rombotis Spiro George","position":1,"cik":"0001357396","reported_name":"Rombotis Spiro George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-11-22T21:05:55.000Z","date":"2021-11-18","kind":"purchase","acquired":true,"shares":4000,"price":4.5,"value":18000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person purchased 4,000 shares of common stock on November 18, 2021."}],"balance_after":4988,"source":{"system":"sec-edgar","filing":"0001104659-21-142474","document":"tm2133647-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465921142474/tm2133647-1_4seq1.xml","form_type":"4"}},{"id":2944941,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":95849,"kind":"person","name":"Rombotis Spiro George","position":1,"cik":"0001357396","reported_name":"Rombotis Spiro George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-15T21:25:09.000Z","date":"2020-12-11","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted as part of the Issuer's annual compensation review to executive officers."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis."}],"balance_after":175000,"derivative":{"exercise_price":4.32,"expiration_date":"2030-12-11","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001104659-20-135749","document":"tm2038414d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465920135749/tm2038414d1_4.xml","form_type":"4"}},{"id":3348353,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":95849,"kind":"person","name":"Rombotis Spiro George","position":1,"cik":"0001357396","reported_name":"Rombotis Spiro George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option","published_at":"2019-12-10T02:01:05.000Z","date":"2019-12-05","kind":"grant","acquired":true,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 22, 2018, Spiro Rombotis was granted an option to purchase certain shares of common stock, which option shall vest according to the satisfaction of performance criteria. Certain performance criteria were confirmed to have been met on December 5, 2019, resulting in the vesting of the option as to 15,625 shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 22, 2018, Spiro Rombotis was granted an option to purchase certain shares of common stock, which option shall vest according to the satisfaction of performance criteria. Certain performance criteria were confirmed to have been met on December 5, 2019, resulting in the vesting of the option as to 15,625 shares."}],"balance_after":15625,"derivative":{"exercise_price":1.56,"expiration_date":"2028-02-22","underlying":"Common Stock","underlying_shares":15625},"source":{"system":"sec-edgar","filing":"0001104659-19-071120","document":"tm1924755d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465919071120/tm1924755d2_4.xml","form_type":"4"}},{"id":3348352,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":95849,"kind":"person","name":"Rombotis Spiro George","position":1,"cik":"0001357396","reported_name":"Rombotis Spiro George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option","published_at":"2019-12-10T02:01:05.000Z","date":"2019-12-05","kind":"grant","acquired":true,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 29, 2017, Spiro Rombotis was granted an option to purchase certain shares of common stock, which option shall vest according to the satisfaction of performance criteria. Certain performance criteria were confirmed to have been met on December 5, 2019, resulting in the vesting of the option as to 15,625 shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On December 29, 2017, Spiro Rombotis was granted an option to purchase certain shares of common stock, which option shall vest according to the satisfaction of performance criteria. Certain performance criteria were confirmed to have been met on December 5, 2019, resulting in the vesting of the option as to 15,625 shares."}],"balance_after":15625,"derivative":{"exercise_price":1.74,"expiration_date":"2027-12-29","underlying":"Common Stock","underlying_shares":15625},"source":{"system":"sec-edgar","filing":"0001104659-19-071120","document":"tm1924755d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465919071120/tm1924755d2_4.xml","form_type":"4"}},{"id":3702267,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":95849,"kind":"person","name":"Rombotis Spiro George","position":1,"cik":"0001357396","reported_name":"Rombotis Spiro George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option","published_at":"2019-01-07T14:26:29.000Z","date":"2019-01-03","kind":"grant","acquired":true,"shares":14375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On February 22, 2018, Spiro Rombotis was granted an option to purchase certain shares of common stock, which option shall vest according to the satisfaction of performance criteria. Certain performance criteria were confirmed to have been met on January 3, 2019, resulting in the vesting of the option as to 14,375 shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 22, 2018, Spiro Rombotis was granted an option to purchase certain shares of common stock, which option shall vest according to the satisfaction of performance criteria. Certain performance criteria were confirmed to have been met on January 3, 2019, resulting in the vesting of the option as to 14,375 shares."}],"balance_after":14375,"derivative":{"exercise_price":1.56,"expiration_date":"2028-02-22","underlying":"Common Stock","underlying_shares":14375},"source":{"system":"sec-edgar","filing":"0001144204-19-000788","document":"tv510488_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000114420419000788/tv510488_4.xml","form_type":"4"}},{"id":3702266,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":95849,"kind":"person","name":"Rombotis Spiro George","position":1,"cik":"0001357396","reported_name":"Rombotis Spiro George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option","published_at":"2019-01-07T14:26:29.000Z","date":"2019-01-03","kind":"grant","acquired":true,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On December 29, 2017, Spiro Rombotis was granted an option to purchase certain shares of common stock, which option shall vest according to the satisfaction of performance criteria. Certain performance criteria were confirmed to have been met on January 3, 2019, resulting in the vesting of the option as to 15,625 shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On December 29, 2017, Spiro Rombotis was granted an option to purchase certain shares of common stock, which option shall vest according to the satisfaction of performance criteria. Certain performance criteria were confirmed to have been met on January 3, 2019, resulting in the vesting of the option as to 15,625 shares."}],"balance_after":15625,"derivative":{"exercise_price":1.74,"expiration_date":"2027-12-29","underlying":"Common Stock","underlying_shares":15625},"source":{"system":"sec-edgar","filing":"0001144204-19-000788","document":"tv510488_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000114420419000788/tv510488_4.xml","form_type":"4"}},{"id":3702265,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":95849,"kind":"person","name":"Rombotis Spiro George","position":1,"cik":"0001357396","reported_name":"Rombotis Spiro George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option","published_at":"2019-01-07T14:26:29.000Z","date":"2019-01-04","kind":"grant","acquired":true,"shares":508198,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted as part of the Issuer's annual compensation review to executive officers."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis."}],"balance_after":508198,"derivative":{"exercise_price":0.71,"expiration_date":"2029-01-04","underlying":"Common Stock","underlying_shares":508198},"source":{"system":"sec-edgar","filing":"0001144204-19-000788","document":"tv510488_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000114420419000788/tv510488_4.xml","form_type":"4"}}]}